Near point-of-care molecular tests for tuberculosis: what will it take to realize their potential?

Samankaltaisia teoksia

• Comparison of Two Field Deployable PCR Platforms for SARS-CoV-2 and Influenza A and B Viruses’ Detection
  Tekijä: Hakim Bouamar, et al.
  Julkaistu: (2025-01-01)
• Comparative performance of the novel, point-of-care Pluslife Mini Dock Dirofilaria immitis/Dirofilaria repens detection test with the modified Knott’s test in dogs
  Tekijä: Tiana L. Sanders, et al.
  Julkaistu: (2026-05-01)
• Characterization of oral swab samples for diagnosis of pulmonary tuberculosis.
  Tekijä: Rachel C Wood, et al.
  Julkaistu: (2021-01-01)
• Near point-of-care molecular tests for tuberculosis: what will it take to realize their potential?
  Tekijä: Claudia M. Denkinger, et al.
  Julkaistu: (2026-05-01)
• Evaluation of the RHAM-based Pluslife Rapid SARS-CoV-2 assay and comparison with EasyNAT Rapid SARS-CoV-2 assay and Wondfo 2019-nCoV antigen assay
  Tekijä: Guosheng Zhong, et al.
  Julkaistu: (2025-12-01)